These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5057724)

  • 1. [Hemolysins and isoagglutinins in substitute preparations containing factor VIII].
    Göbel U; Ranke M
    Blut; 1972 Jun; 24(6):365-71. PubMed ID: 5057724
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications of hemophilia A treatment: factor VIII inhibitors.
    Kasper CK
    Ann N Y Acad Sci; 1991; 614():97-105. PubMed ID: 1902643
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies.
    Hach-Wunderle V; Teixidor D; Zumpe P; Kühnl P; Scharrer I
    Infusionstherapie; 1989 Jun; 16(3):100-1. PubMed ID: 2503450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of haemophilia A with concentrated preparations of factor VIII.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Bibl Haematol; 1968; 29():1166. PubMed ID: 5303859
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemophilia home transfusion program: effect of cryoprecipitate utilization.
    Lazerson J
    J Pediatr; 1973 May; 82(5):857-9. PubMed ID: 4698962
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemolysis due to anti-A and anti-B in factor VIII preparations.
    Seeler RA
    Arch Intern Med; 1972 Jul; 130(1):101-3. PubMed ID: 4537633
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to factor VIII: specificity and kinetics of iso- and hetero-antibodies in hemophilia A.
    Allain JP; Frommel D
    Blood; 1974 Sep; 44(3):313-22. PubMed ID: 4604102
    [No Abstract]   [Full Text] [Related]  

  • 9. [The characterization of isoagglutinins depending on the study technic].
    Kessler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):387-92. PubMed ID: 4193021
    [No Abstract]   [Full Text] [Related]  

  • 10. Fractions rich in factor VIII.
    Biggs R
    Bibl Haematol; 1968; 29():1122-6. PubMed ID: 5750137
    [No Abstract]   [Full Text] [Related]  

  • 11. Gm types and antibodies in multitransfused haemophiliacs.
    Kernoff PB; Bowell PJ
    Br J Haematol; 1973 Apr; 24(4):443-50. PubMed ID: 4715141
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-assayed AHF concentrate therapy for hemophilia.
    Peterson CA; Borucki DT; Austin G
    Bibl Haematol; 1968; 29():1160-5. PubMed ID: 5303858
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemophilia home transfusion program: effect on school attendance.
    Lazerson J
    J Pediatr; 1972 Aug; 81(2):330-2. PubMed ID: 5042492
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantity of hemolytic anti-A and anti-B in individuals of a human population: correlations with isoagglutinins and effects of the individual's age and sex.
    Grundbacher FJ
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):317-49. PubMed ID: 4233546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Improvement in anti-hemophilic preparations and its problems. 3. Treatment of hemophilia patients with inhibitors; induction of immune tolerance by a low or intermediate dose regimen].
    Iizuka A
    Rinsho Ketsueki; 1988 May; 29(5):640-8. PubMed ID: 3145995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis-associated antigen and antibodies after multiple transfusions in children and juveniles with severe and moderately severe haemophilia (author's transl)].
    Schwartz B; Landbeck G
    Dtsch Med Wochenschr; 1973 Oct; 98(43):2016-9. PubMed ID: 4744372
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII inhibitors in hemophilia.
    Mariani G
    Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical modelling issues in the RODIN study.
    Moorehead PC
    Haemophilia; 2014 Jul; 20(4):e351-2. PubMed ID: 24827780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.